Although the vast majority of neuroectodermal tumors, carcinomas, and lymphomas were found to be FAP negative, expression was observed in the reactive stroma that surrounds many of these tumors, suggesting that FAP has a role in mesenchymal activation. The gene discussed is FAP; the disease is primitive neuroectodermal tumor.